نتایج جستجو برای: cell therapy

تعداد نتایج: 2205982  

Journal: :acta medica iranica 0
babak arjmand endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran. parisa goodarzi brain and spinal cord injury research center, neurosciences institute, tehran university of medical sciences, tehran, iran. fereshteh mohamadi-jahani brain and spinal cord injury research center, neurosciences institute, tehran university of medical sciences, tehran, iran. khadijeh falahzadeh endocrinology and metabolism research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran. bagher larijani diabetes research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran.

personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. this approach has established based on pharmacogenetic and pharmacogenomic information and data. the terms precision and personalized medicines are sometimes applied interchangeably. however, there has been a shift from “personalized medicine” towards “precision me...

Elahe Mahdipour

Stem cells are cells with the ability to divide for indefinite periods and to give rise to specialized cells.  Stem cell therapy has now been emerged as an extraordinary promise to treat a wide range of diseases and conditions.  However, except blood stem cell transfer by bone marrow transplant which has been used as an standard practice for more than 50 years, nearly all of therapeutic potenti...

ژورنال: کومش 2019
Azizidoost, Shirin, Jorfi, Fatemeh, Mansournezhad, Somayeh, Saki, Najmaldin, Shahrabi, Saeid,

Introduction: Cardiovascular diseases (CVD) are the primary cause of death worldwide, and the development of scar tissue in myocardium and also the irreversible destruction of cardiomyocytes are the main factors in their development. There are still limitations in medical treatment of CVD, despite the advances in the field of drug therapy and surgery for CVD. In recent years, research on stem c...

Journal: :international journal of pediatrics 0
jalil tavakol afshari professor of allergy and immunolgy medical school, mashhad university of medical sciences, mashhad, iran.

the ability to culture human stem cells long term, and possibly indefinitely, and to control how such cells specialise to form the different tissues of the body offers the possibility of major advances in healthcare. stem cells have been isolated and cultured, but a great deal of research is required to develop cell lines which can generate replacement cells and tissues to treat many diseases.s...

Journal: :iranian journal of public health 0
ali tootee ensieh nasli esfahani maryam ghodsi farideh razi hos­sein adibi ramin heshmat

background: although the pathogenesis of diabetes type 1 (t1d) is not fully elucidated. different clusters of lymphocytes such as cd4+ and cd8+ t cells are involved in it. moreover, the mechanism of how stem-cell therapy results in significant therapeutic outcomes in diabetes remains obscure. in the current study, we aimed to analyze lymphocyte subsets in patients with t1d before and after trea...

Journal: :medical hypothesis, discovery and innovation ophthalmology journal 0
harvey uy pik sha chan franz marie cruz

800x600 unfortunately, at present, degenerative retinal diseases such as retinitis pigmentosa remains untreatable. patients with these conditions suffer progressive visual decline resulting from continuing loss of photoreceptor cells and outer nuclear layers. however, stem cell therapy is a promising approach to restore visual function in eyes with degenerative retinal diseases such as retiniti...

Journal: :international journal of hematology-oncology and stem cell research 0
m mohyeddin bonab hematology-oncology & bmt research center s yazdanbakhsh department of neurology, shariati hospital, tehran iran k alimoghaddom hematology-oncology & bmt research center a ghavamzadeh hematology-oncology & bmt research center f hooshmand 3iranian ms society, tehran iran j lotfi iranian ms society, tehran iran

human mesenchymal stem cell (msc) can be isolated from bone marrow (bm) and differentiated into multiple lineages. these properties make them promising tools in cell and gene therapy. up to now, no definite therapeutic intervention for late stages of multiple sclerosis (ms) has been found. we decided to inject ms patients with autologous expanded msc. five patients participated in this ongoing ...

Journal: :international journal of hematology-oncology and stem cell research 0
saeed mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohsen nikbakht hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ashraf malek mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mahdi zahed panah school of allied medical sciences, qazvin university of medical sciences, qazvin, iran mohammad reza ostadali hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran hajar nasiri hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

background: mesenchymal stromal cells (mscs) are employed in various different clinical settings in order to modulate immune response. human autologous and allogeneic supplements including platelet derivatives such as platelet lysate (pl), platelet-released factors (prf) and serum are assessed in clinical studies to replace fetal bovine serum (fbs). the immunosuppressive activity and multi-pote...

Journal: :international journal of hematology-oncology and stem cell research 0
kamran alimoghaddam mohamad jahani seyyedasadollah mousavi babak bahar amirali hamidieh mohammad vaezi

introduction: despite achievement to complete remission (cr) with current treatments and new multiple chemotherapeutic agents in acute lymphoblastic leukemia (all) patients, the majority of them still relapse during long-term follow-up. the use of post- remission therapy will reduce early relapse in these cases, but the best option is still debatable. patients and methods: in this retrospective...

Journal: :iranian journal of immunology 0
mitra rafiee department of immunology, school of medicine marjan gharagozloo department of immunology, school of medicine ataollah ghahiri department of gynecology and obstetrics, al-zahra university hospital ferdous mehrabian department of gynecology and obstetrics, al-zahra university hospital mohammad r. maracy department of community medicine, school of medicine, isfahan university of medical sciences, isfahan, iran shirin kouhpayeh department of immunology, school of medicine ina laura pieper

background: recurrent miscarriage (rm) affects 2-5% of pregnant women. paternal lymphocyte immunotherapy is a common treatment for rm patients but the outcome has not been consistent. therefore, combined therapy with other immunosuppressive drugs such as 1 a, 25-dihydroxy-vitamin-d3 (vitamin d3) may improve the outcome. objectives: to investigate the effect of vitamin d3 on the balance of two e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید